scispace - formally typeset
F

Fehmida Visnegarwala

Researcher at Baylor College of Medicine

Publications -  34
Citations -  6524

Fehmida Visnegarwala is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Viral load & Insulin resistance. The author has an hindex of 22, co-authored 34 publications receiving 6410 citations. Previous affiliations of Fehmida Visnegarwala include Michael E. DeBakey Veterans Affairs Medical Center in Houston & Morehouse School of Medicine.

Papers
More filters
Journal ArticleDOI

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

Daniel D Murray, +1489 more
- 14 Oct 2015 - 
TL;DR: No associations with mortality were found with any circulating miRNAs studied and these results cast doubt onto the effectiveness of circulating miRNA as early predictors of mortality or the major underlying diseases that contribute to mortality in participants treated for HIV-1 infection.
Journal ArticleDOI

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

TL;DR: IRIS is common among HIV-infected persons coinfected with M. tuberculosis, M. avium complex, or C. neoformans and patients who start HAART in close proximity to the diagnosis of an opportunistic infection and have a rapid decline in HIV-1 RNA level should be monitored for development of this disorder.
Journal ArticleDOI

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.

TL;DR: The present understanding of the basic science underlying IRIS is reviewed, with illustrative examples from the authors' case series, and the existing clinical literature is reviewed.
Journal ArticleDOI

The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy.

TL;DR: This study of human immunodeficiency virus (HIV)-infected patients coinfected with Cryptococcus neoformans found that 30% of patients who initiated highly active antiretroviral therapy developed immune reconstitution inflammatory syndrome (IRIS).
Journal ArticleDOI

Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort.

TL;DR: With the use of potent antiretroviral therapy in patients with HIV disease, changes in lipid parameters and glucose homeostasis have been noted, but these effects have been difficult to interpret because of the varied demographic and treatment characteristics of the cohorts.